Skip to main content

Maria Mar Hernandez Guillamon

Senior Researcher, Neurovascular Research Lab, VHIR.

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Maria Mar Hernandez Guillamon

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Senior Researcher, Neurovascular Research Lab, VHIR.

Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.

Projects

Proyecto colaborativo europeo-latinoamericano y caribeño sobre medicina personalizada para el estudio de trastornos neurológicos

IP: Maria Mar Hernandez Guillamon
Collaborators: Anna Penalba Morenilla, Jessica Camacho Soriano, Anas Chaachou Charradi, Elena Antima Martinez Saez
Funding agency: Instituto de Salud Carlos III
Funding: 174845
Reference: AC22/00051
Duration: 01/01/2023 - 31/12/2025

RICORS-ICTUS

IP: Anna Rosell Novel
Collaborators: Marcel Lamana Vallverdu, Anna Penalba Morenilla, RICORS-ICTUS , Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Maria Pilar Delgado Martínez, Jesús Pizarro Gonzálvez
Funding agency: Instituto de Salud Carlos III
Funding: 250214.8
Reference: RD21/0006/0007
Duration: 01/01/2022 - 31/12/2024

IBCAA Snowball - Image guided non-invasive brain stimulation for safe and therapeutically effective modulation of blood-brain-barrier function and neural networks in cerebral amyloid angiopathy

IP: Maria Mar Hernandez Guillamon
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding:
Reference: EC/ERANET_JNPD/2020/HERNANDEZ
Duration: -

Implicaction of proteins associated with vascular beta-amyloid in Cerebral Amyloid Angiopathy

IP: Maria Mar Hernandez Guillamon
Collaborators: Marcel Lamana Vallverdu, Implicaction of proteins associated with vascular beta-amyloid in Cerebral Amyloid Angiopathy, Jessica Camacho Soriano, Olga Maisterra Santos, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 169400
Reference: PI20/00465
Duration: 01/01/2021 - 30/06/2025

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Irene  Torrecilla Martinez

Irene Torrecilla Martinez

Epidemiology and Public Health
Read more
Jorge Pérez López

Jorge Pérez López

Genetics Medicine
Read more
Genoveva Arqueros Sánchez

Genoveva Arqueros Sánchez

Tècnic/a Grau Superior
Labour Relations Unit
Human Resources Directorate
Read more
Mª Eulàlia Joseph Munné

Mª Eulàlia Joseph Munné

Medium Grade Technician
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.